Search

Search Constraints

You searched for: Author/Creator Yaromina, Ala

Search Results

2. Combination of radiotherapy with the immunocytokine L19-IL2: Additive effect in a NK cell dependent tumour model. Issue 3 (September 2015)

3. Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity. (December 2019)

4. Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity. Issue 3 (September 2017)

5. Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials. (February 2019)

6. Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours. Issue 3 (December 2016)

7. Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells. Issue 3 (September 2015)

8. New ways to image and target tumour hypoxia and its molecular responses. Issue 3 (September 2015)

9. Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial. (March 2020)

10. Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy. Issue 3 (9th March 2021)